Specificity of catecholamine-induced growth in Escherichia coli O157:H7, Salmonella enterica and Yersinia enterocolitica

FEMS Microbiology Letters

Volumn 269, Issue 2, 2007, Pages 221-228

  Freestone, Primrose P E ^a   Haigh, Richard D ^a   Lyte, Mark ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Dopamine; Enteric pathogens; Epinephrine; Iron; Norepinephrine

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; NORADRENALIN;

ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI O157; HOST PATHOGEN INTERACTION; INTESTINE INNERVATION; NERVE CELL; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; YERSINIA ENTEROCOLITICA;

BACTERIOLOGICAL TECHNIQUES; CATECHOLAMINES; COLONY COUNT, MICROBIAL; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; ESCHERICHIA COLI O157; HUMANS; SALMONELLA ENTERICA; SPECIES SPECIFICITY; YERSINIA ENTEROCOLITICA;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; SALMONELLA ENTERICA; YERSINIA ENTEROCOLITICA;

EID: 33847034492     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2006.00619.x     Document Type: Article

References (26)

1. Andrade-Mena CE (1997) Inhibition of gamma interferon synthesis by catecholamines. J Neuroimmunol 76: 10-14.
2. Belay T & Sonnenfeld G (2002) Differential effects of catecholamines on in vitro growth of pathogenic bacteria. Life Sci 71: 447-456.
3. Belay T, Aviles H, Vance M, Fountain K & Sonnenfeld G (2003) Catecholamines and in vitro growth of pathogenic bacteria: enhancement of growth varies greatly among bacterial species. Life Sci 73: 1527-1535.
4. Burton CL, Chhabra SR, Swift S, Baldwin TJ, Withers H, Hill SJ & Williams P (2002) The growth response of Escherichia coli to neurotransmitters and related catecholamine drugs requires a functional enterobactin biosynthesis and uptake system. Infect Immun 70: 5913-5923.
5. Clarke MB, Hughes DT, Zhu C, Boedeker EC & Sperandio V (2006) The QseC sensor kinase: a bacterial adrenergic receptor. Proc Natl Acad Sci USA 103: 10420-10425.
6. Costa M, Brookes SJ & Hennig GW (2000) Anatomy and physiology of the enteric nervous system. Gut 47: (Suppl 4): iv15-iv19; discussion iv26.
7. Eisenhofer G, Aneman A, Hooper D, Rundqvist B & Friberg P (1996) Mesenteric organ production, hepatic metabolism, and renal elimination of norepinephrine and its metabolites in humans. J Neurochem 66: 1565-1573.
8. Freestone PP, Haigh RD, Williams PH & Lyte M (1999) Stimulation of bacterial growth by heat-stable, norepinephrine-induced autoinducers. FEMS Microbiol Lett 172: 53-60.
9. Freestone PP, Lyte M, Neal CP, Maggs AF, Haigh RD &Williams PH (2000) The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferrin or lactoferrin. J Bacteriol 182: 6091-6098.
10. Freestone PP, Williams PH, Haigh RD, Maggs AF, Neal CP & Lyte M (2002) Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock 18: 465-470.
11. Freestone PP, Haigh RD, Williams PH & Lyte M (2003) Involvement of enterobactin in norepinephrine-mediated iron supply from transferrin to enterohaemorrhagic Escherichia coli. FEMS Microbiol Lett 222: 39-43.
12. Kinney KS, Austin CE, Morton DS & Sonnenfeld G (1999) Catecholamine enhancement of Aeromonas hydrophila growth. Microb Pathog 26: 85-91.
13. Kinney KS, Austin CE, Morton DS & Sonnenfeld G (2000) Norepinephrine as a growth stimulating factor in bacteria - mechanistic studies. Life Sci 67: 3075-3085.
14. Leinhardt DJ, Arnold J, Shipley KA, Mughal MM, Little RA & Irving MH (1993) Plasma NE concentrations do not accurately reflect sympathetic nervous system activity in human sepsis. Am J Physiol 265: E284-E288.
15. Lyte M (1992) The role of catecholamines in gram-negative sepsis. Med Hypotheses 37: 255-258.
16. Lyte M (1993) The role of microbial endocrinology in infectious disease. J Endocrinol 137: 343-345.
17. Lyte M (2004) Microbial endocrinology and infectious disease in the 21st century. Trends Microbiol 12: 14-20.
18. Lyte M & Ernst S (1992) Catecholamine induced growth of gram negative bacteria. Life Sci 50: 203-212.
19. Lyte M, Freestone PP, Neal CP, Olson BA, Haigh RD, Bayston R & Williams PH (2003) Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet 361: 130-135.
20. Meirieu O, Pairet M, Sutra JF & Ruckebusch M (1986) Local release of monoamines in the gastrointestinal tract: an in vivo study in rabbits. Life Sci 38: 827-834.
21. Mobley P & Greengard P (1985) Evidence for widespread effects of noradrenaline on axon terminals in the rat frontal cortex. Proc Natl Acad Sci USA 82: 945-947.
22. Neal CP, Freestone PP, Maggs AF, Haigh RD,Williams PH & Lyte M (2001) Catecholamine inotropes as growth factors for Staphylococcus epidermidis and other coagulase-negative staphylococci. FEMS Microbiol Lett 194: 163-169.
23. Reissbrodt R, Rienaecker I, Romanova JM et al. (2002) Resuscitation of Salmonella enterica serovar typhimurium and enterohemorrhagic Escherichia coli from the viable but nonculturable state by heat-stable enterobacterial autoinducer. Appl Environ Microbiol 68: 4788-4794.
24. Sanders VM & Munson AE (1984) Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro. J Pharmacol Exp Ther 230: 183-192.
25. Tarr PI & Neill MA (2001) Escherichia coli O157:H7. Gastroenterol Clin North Am 30: 735-751.
26. Walters M & Sperandio V (2006) Quorum sensing in Escherichia coli and Salmonella. Int J Med Microbiol 296: 125-131.